NSB.AX

Healthcare Biotechnology

NeuroScientific Biopharmaceuticals Limited

A$0.06

+0.00 +1.61% today

Price History

Not enough data

Key Stats

Market Cap

24.55M

Avg Volume

158,995

EPS

-A$0.01

52W High

A$0.18

52W Low

A$0.06

Div. Yield

0.0%

Valuation

P/B Ratio

1.66

P/S Ratio

60.98

EV/EBITDA

-5.91

EV/Revenue

48.73

Margins

Gross Margin 64.1%

Operating Margin (3407.5%)

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Revenue Growth (YoY)

87.6%

Return on Equity

(29.7%)

Return on Assets

(18.3%)

Liquidity & Leverage

Current Ratio

14.27

Quick Ratio

14.15

Debt / Equity

0.01

Total Cash

4.63M

Total Debt

87,039

About

NeuroScientific Biopharmaceuticals Limited engages in the research and development of biomedical products targeting neurodegenerative conditions and immune-mediated inflammatory diseases. Its lead product is the EmtinB drug for the treatment of optic nerve diseases, such as glaucoma. The company also develops StemSmart platform technology to treat inflammatory immune disorders. NeuroScientific Biopharmaceuticals Limited was incorporated in 2002 and is based in Perth, Australia.